Dr Helena Andersson on long-term experience with rituximab

from The Rheumatology Podcast · host Oxford University Press

Professor Jaap van Laar interviews Dr Helena Andersson, Oslo University, regarding her study on long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.

Episode metadata supplied by the publisher feed · Published Feb 12, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Dr Helena Andersson on long-term experience with rituximab

0:00 5:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rheumatology Podcast?

This episode is 5 minutes long.

When was this The Rheumatology Podcast episode published?

This episode was published on February 12, 2018.

Can I download this The Rheumatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!